@article{ajmcr20221065,
author={{Sah, Anuraag and Fichadiya, Hardik and Noori, Muhammed Atif Masood and Khan, Arshan and Fichadiya, Harshil and Latif, Asnia and Khazaei, Maria and Zaboski, Michael},
title={COVID-induced Immune-mediated Necrotizing Myositis: an Atypical Presentation of Rhabdomyolysis with Breakthrough COVID-19 Infection ¨C A Case Report},
journal={American Journal of Medical Case Reports},
volume={10},
number={6},
pages={180--182},
year={2022},
url={http://pubs.sciepub.com/ajmcr/10/6/5},
issn={2374-216X},
abstract={Immune-mediated necrotizing myopathy (IMNM) is an inflammatory myopathy characterized by proximal muscle weakness and significantly elevated creatinine kinase levels. IMNM occurs primarily in adults and is usually rapidly progressive in nature. It can be seronegative or associated with antibodies against signal recognition peptide (SRP) or hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR). Scarce and rare cases of Immune-mediated necrotizing myopathy have recently been observed in muscle biopsy of COVID-19 patients with similar histological and clinical features of other IMNM with profound proximal muscle weakness and elevated CPK levels. We present a very interesting case of an atypical presentation of IMNM in the presence of COVID-19 infection. Treatment with Remdesivir and dexamethasone resulted in improvement of her symptoms.},
doi={10.12691/ajmcr-10-6-5}
publisher={Science and Education Publishing}
}